Canada · 
Who invested in Inversago?
Inversago's investors include Anges Quebec, Genesys Capital, Accel-Rx, Amorchem/ JDRF T1D Fund and Tarnagulla.
Canada · Series A startup
Who invested in Inversago
One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$7.0Mraised across 1 round since 2018, from 1 source
- Latest round
- Series A, $7.0MJul 2018
- Investors
- 5
The rounds
- Jul 2018Series A$7.0M
Anges Quebec
Genesys Capital- Accel-Rx
- Amorchem/ JDRF T1D Fund
- Tarnagulla
Reported by FinSMEs
Everyone who backed them
Accel-Rxno record of our own yet1round
Amorchem/ JDRF T1D Fundno record of our own yet1round
Tarnagullano record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 3 firms list Inversago as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Inversago
How much has Inversago raised?
Inversago has raised $7.0M across 1 round since 2018.
When did Inversago last raise?
Inversago's most recent round was a Series A of $7.0M in Jul 2018.
What was Inversago's biggest round?
Its most recent round, $7.0M in Jul 2018, is also its largest on record.
Who backed Inversago first?
Inversago's first round on record, in Jul 2018, was backed by Anges Quebec, Genesys Capital and Accel-Rx and 2 others.
What stage is Inversago at?
Inversago's latest named round is a Series A, in Jul 2018.
Where is Inversago based?
Inversago is based in Canada.
Companies like Inversago
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.